Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.11% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PARA
876
DELISTED
Paramount Global Class B
PARA
| $23.5M | 0.02% |
471,700
+114,500
| +32% | +$5.67M |
|
|
SPPI
877
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $23.5M | 0.02% |
2,726,317
+1,034,135
| +61% | +$9.25M |
|
878
Range Resources
RRC
$9.39B
| $23.5M | 0.02% |
+3,362,229
| New | +$29.2M |
|
879
Camden National
CAC
$990M
| $23.5M | 0.02% |
511,400
+23,451
| +5% | +$1.03M |
|
880
Methode Electronics
MEI
$602M
| $23.3M | 0.02% |
816,680
+24,880
| +3% | +$697K |
|
881
MongoDB
MDB
$35.2B
| $23.3M | 0.02% |
153,400
-491,700
| -76% | -$71.4M |
|
|
HUYA
882
Huya Inc
HUYA
$547M
| $23.3M | 0.02% |
+942,500
| New | +$21.7M |
|
|
CFMS
883
DELISTED
Conformis, Inc. Common Stock
CFMS
| $23.2M | 0.02% |
213,055
+42,610
| +25% | +$3.51M |
|
|
MODN
884
DELISTED
MODEL N, INC.
MODN
| $23.2M | 0.02% |
1,189,000
+121,700
| +11% | +$2.24M |
|
885
Enphase Energy
ENPH
$5.39B
| $23.2M | 0.02% |
1,270,628
+1,010,100
| +388% | +$13.9M |
|
886
Algonquin Power & Utilities
AQN
$4.44B
| $23.1M | 0.02% |
1,909,751
+259,751
| +16% | +$3.04M |
|
887
Independent Bank Corp
IBCP
$850M
| $23.1M | 0.02% |
1,060,500
-38,200
| -3% | -$827K |
|
888
ON Semiconductor
ON
$32.4B
| $23.1M | 0.02% |
1,142,796
+207,000
| +22% | +$4.28M |
|
889
Equitable Holdings
EQH
$14.1B
| $23M | 0.02% |
+1,099,400
| New | +$23.7M |
|
890
Tesla
TSLA
$1.29T
| $22.9M | 0.02% |
1,540,125
-5,463,255
| -78% | -$85M |
|
891
Lindblad Expeditions
LIND
$2.24B
| $22.9M | 0.02% |
1,276,479
+340,800
| +36% | +$5.6M |
|
|
IMOS
892
ChipMOS TECHNOLOGIES
IMOS
$1.96B
| $22.9M | 0.02% |
1,487,676
+25,009
| +2% | +$408K |
|
|
CHS
893
DELISTED
Chicos FAS, Inc.
CHS
| $22.9M | 0.02% |
6,785,100
+492,900
| +8% | +$1.79M |
|
894
Blackstone Mortgage Trust
BXMT
$2.41B
| $22.7M | 0.02% |
639,280
+83,000
| +15% | +$2.95M |
|
895
EPAM Systems
EPAM
$5.17B
| $22.7M | 0.02% |
+131,400
| New | +$22.6M |
|
896
Credit Acceptance
CACC
$5.99B
| $22.7M | 0.02% |
47,003
+45,315
| +2,685% | +$21.5M |
|
897
Amdocs
DOX
$6.08B
| $22.7M | 0.02% |
365,800
-419,300
| -53% | -$24.2M |
|
898
RadNet
RDNT
$6.06B
| $22.7M | 0.02% |
1,644,703
-203,300
| -11% | -$2.61M |
|
899
Extreme Networks
EXTR
$3.2B
| $22.7M | 0.02% |
3,503,673
+957,610
| +38% | +$6.33M |
|
900
Hawaiian Electric Industries
HE
$2.06B
| $22.7M | 0.02% |
520,500
-239,900
| -32% | -$10.1M |
|
Similar funds
Jim Simons's Q2 2019 Portfolio in Review
As of Q2 2019, Jim Simons held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Jim Simons's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Jim Simons added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Jim Simons's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Jim Simons fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Jim Simons's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Jim Simons opened 495 new positions and closed 397 in Q2 2019.
- Jim Simons's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.